Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine. [version 1; peer review: 2 approved]

Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine. [version 1; peer review: 2 approved]

A systematic review of clinical trials conducted with a low-dose inactivated influenza vaccine adjuvanted by azoximer bromide (AZB, Polyoxidonium), was performed to compare vaccine reactogenicity against non-adjuvant vaccines. We also assessed whether lower amounts of antigen per viral strain in AZB...

Full description

Bibliographic Details
Main Authors: Susanna Kharit, Dmitry Lioznov, Michail Kostinov, Ronald Kompier, Tim Hardman, Walter Beyer, Pieter Neels
Format: Article
Language:English
Published: F1000 Research Ltd 2022-03-01
Series:F1000Research
Subjects:
influenza vaccine
vaccine adjuvant
azoximer bromide
vaccine safety
immunogenicity
review
eng
Online Access:https://f1000research.com/articles/11-259/v1

Similar Items

Similar Items